Your browser doesn't support javascript.
loading
Effect of noninvasive ventilation on mortality and clinical outcomes among patients with severe hypoxemic COVID-19 pneumonia after high-flow nasal oxygen failure: a multicenter retrospective French cohort with propensity score analysis.
Goury, Antoine; Houlla, Zeyneb; Jozwiak, Mathieu; Urbina, Tomas; Turpin, Matthieu; Lavalard, Alexandra; Laghlam, Driss; Voicu, Sebastian; Rosman, Jeremy; Coutureau, Claire; Mourvillier, Bruno.
Affiliation
  • Goury A; Unité de Médecine Intensive et Réanimation Polyvalente, CHU Reims, Reims, F-51100, France. agoury@chu-reims.fr.
  • Houlla Z; Unité de Médecine Intensive et Réanimation Polyvalente, CHU Reims, Reims, F-51100, France.
  • Jozwiak M; Service de Médecine Intensive Réanimation, Centre Hospitalier Universitaire de Nice, Hôpital l'Archet 1, Nice, France.
  • Urbina T; UR2CA - Unité de Recherche Clinique Côte d'Azur, Université Côte d'Azur, Nice, France.
  • Turpin M; Service de Médecine Intensive Réanimation, Hôpital Saint-Antoine, Assistance Publique Hôpitaux de Paris, Paris, France.
  • Lavalard A; Service de Médecine Intensive Réanimation, Hôpital Tenon, Assistance Publique Hôpitaux de Paris, Paris, France.
  • Laghlam D; Unité de Réanimation Polyvalente, Centre Hospitalier de Troyes, Troyes, France.
  • Voicu S; Service de Médecine Intensive et Réanimation, Hôpital Cochin, Assistance Publique Hôpitaux de Paris, Paris, France.
  • Rosman J; Réanimation Médicale et Toxicologique, Hôpital Lariboisière, Assistance Publique Hôpitaux de Paris, Paris, France.
  • Coutureau C; Unité de Soins Intensifs et Réanimation, Groupe Hospitalier de Territoire Nord-Ardennes, Charleville-Mézières, France.
  • Mourvillier B; Université de Reims Champagne-Ardenne, VieFra, Reims, F-51100, France.
Respir Res ; 25(1): 279, 2024 Jul 15.
Article de En | MEDLINE | ID: mdl-39010097
ABSTRACT

BACKGROUND:

We assessed the effect of noninvasive ventilation (NIV) on mortality and length of stay after high flow nasal oxygenation (HFNO) failure among patients with severe hypoxemic COVID-19 pneumonia.

METHODS:

In this multicenter, retrospective study, we enrolled COVID-19 patients admitted in intensive care unit (ICU) for severe COVID-19 pneumonia with a HFNO failure from December 2020 to January 2022. The primary outcome was to compare the 90-day mortality between patients who required a straight intubation after HFNO failure and patients who received NIV after HFNO failure. Secondary outcomes included ICU and hospital length of stay. A propensity score analysis was performed to control for confounding factors between groups. Exploratory outcomes included a subgroup analysis for 90-day mortality.

RESULTS:

We included 461 patients with HFNO failure in the analysis, 233 patients in the straight intubation group and 228 in the NIV group. The 90-day mortality did not significantly differ between groups, 58/228 (25.4%) int the NIV group compared with 59/233 (25.3%) in the straight intubation group, with an adjusted hazard ratio (HR) after propensity score weighting of 0.82 [95%CI, 0.50-1.35] (p = 0.434). ICU length of stay was significantly shorter in the NIV group compared to the straight intubation group, 10.0 days [IQR, 7.0-19.8] versus 18.0 days [IQR,11.0-31.0] with a propensity score weighted HR of 1.77 [95%CI, 1.29-2.43] (p < 0.001). A subgroup analysis showed a significant increase in mortality rate for intubated patients in the NIV group with 56/122 (45.9%), compared to 59/233 (25.3%) for patients in the straight intubation group (p < 0.001).

CONCLUSIONS:

In severely hypoxemic COVID-19 patients, no significant differences were observed on 90-day mortality between patients receiving straight intubation and those receiving NIV after HFNO failure. NIV strategy was associated with a significant reduction in ICU length of stay, despite an increase in mortality in the subgroup of patients finally intubated.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Oxygénothérapie / Score de propension / Ventilation non effractive / COVID-19 Limites: Aged / Aged80 / Female / Humans / Male / Middle aged Pays/Région comme sujet: Europa Langue: En Journal: Respir Res Année: 2024 Type de document: Article Pays d'affiliation: France

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Oxygénothérapie / Score de propension / Ventilation non effractive / COVID-19 Limites: Aged / Aged80 / Female / Humans / Male / Middle aged Pays/Région comme sujet: Europa Langue: En Journal: Respir Res Année: 2024 Type de document: Article Pays d'affiliation: France